Testosterone replacement therapy (TRT) improves body composition, sexual function, bone strength, mood, and metabolic health in men with clinically low testosterone, defined as a total testosterone level below 300 ng/dL on two separate morning blood draws. The benefits don’t arrive all at once. Some changes, like improvements in energy and libido, begin within the first few weeks, while shifts in muscle mass and fat loss take three to six months to fully materialize.
These benefits apply specifically to men with diagnosed testosterone deficiency, not to men with normal levels looking for a performance boost. The American Urological Association is clear that a diagnosis requires both low blood levels and symptoms like fatigue, low sex drive, or loss of muscle mass.
Muscle Gain and Fat Loss
The most visible benefit of TRT is a shift in body composition: more lean tissue, less fat. Men with testosterone levels in the top 25% carry roughly 22% more lower-body lean mass and 6% more upper-body lean mass than men in the bottom 25%. They also carry about 10% less lower-body fat and 6% less upper-body fat. When hypogonadal men bring their levels into a healthy range through treatment, this recomposition effect kicks in.
The muscle-building potential is substantial even without exercise. In one study, ten weeks of testosterone injections increased quadriceps muscle size and boosted squatting strength by 19% in men who did no resistance training at all. Combine TRT with a consistent lifting program, and the results are more pronounced. Noticeable body composition changes typically begin around week 12 and continue stabilizing over 6 to 12 months.
Sexual Function and Libido
Low testosterone is one of the most common treatable causes of declining sexual function in men. A meta-analysis of 14 trials covering nearly 2,300 men found that testosterone therapy significantly improved erectile function scores compared to placebo. It also improved libido, orgasm quality, intercourse satisfaction, and overall sexual satisfaction across the board.
The degree of improvement depends on how low your levels are to begin with. Men with more severe deficiency (total testosterone below about 230 ng/dL) saw roughly twice the improvement in erectile function scores compared to men with milder deficiency. This makes sense: the further you are from normal, the more ground there is to recover.
Most men notice the first signs of returning libido and morning erections around weeks 3 to 4 of treatment. Erectile function and desire continue improving through weeks 7 and 8, then tend to level off at a stronger, more consistent baseline by weeks 9 through 12.
Mood, Anxiety, and Focus
Men on TRT report measurably lower levels of depression, anxiety, and attention difficulties compared to untreated men with low testosterone. In a study of middle-aged men, the treatment group scored significantly better across all three categories. The improvements were statistically meaningful, though modest in size. TRT isn’t a replacement for mental health treatment, but for men whose mood issues stem at least partly from hormonal deficiency, restoring normal levels removes one contributing factor.
The mood timeline is among the fastest to show results. Reduced fatigue and irritability can appear within the first two weeks. By weeks 3 to 4, stress tolerance improves. Most men describe a stable, predictable emotional baseline by weeks 7 to 8, with mental clarity and motivation continuing to sharpen through week 12.
Bone Density
Testosterone plays a direct role in maintaining bone mineral density, and men with low levels are at higher risk of osteoporosis and fractures. TRT can partially reverse this. In a study of hypogonadal men treated for two years, trabecular bone density in the spine increased by about 13%. Another group saw spinal bone density rise from an average of 95 mg/cm³ to 120 mg/cm³ after the first year, with further gains continuing through year two and beyond.
These improvements are clinically meaningful, especially for older men. Bone remodeling is slow, so density gains take at least 6 to 12 months to become measurable on a scan and continue accumulating over several years of treatment.
Blood Sugar and Metabolic Health
For men with both low testosterone and type 2 diabetes, TRT offers a metabolic benefit. A meta-analysis found that testosterone therapy reduced HbA1c (a marker of long-term blood sugar control) by a significant margin compared to placebo. Reductions in insulin resistance, fasting glucose, and fasting insulin also trended in the right direction, though those individual results didn’t reach statistical significance.
The practical takeaway: TRT won’t replace diabetes management, but it can make blood sugar modestly easier to control in men who are also testosterone-deficient. The mechanism ties back to body composition. Less visceral fat and more muscle mass both improve the body’s ability to process glucose.
Memory and Spatial Thinking
There’s evidence that testosterone influences certain types of cognitive performance. In a controlled trial of men with Alzheimer’s disease and mild cognitive impairment, those receiving testosterone showed improvements in spatial memory, constructional abilities (like drawing and assembling shapes), and verbal memory compared to the placebo group. The placebo group’s verbal memory actually declined over the six-week study period, while the treatment group’s held steady or improved.
These benefits were specific to memory tasks. The study found no changes in attention, language, or verbal fluency, suggesting testosterone’s cognitive effects are limited to particular domains rather than being a broad mental enhancer.
When Each Benefit Appears
One of the most practical things to know about TRT is that the timeline is staggered. Here’s what to expect:
- Weeks 1 to 2: Slight uptick in motivation and focus. Reduced fatigue and irritability.
- Weeks 3 to 4: Morning erections return for many men. Sexual interest picks up. Stress feels more manageable.
- Weeks 5 to 8: Sexual function and desire improve more consistently. Energy and mood feel stable day to day. Small body composition changes begin.
- Weeks 9 to 12: Libido reaches a more predictable baseline. Lean muscle gains and fat loss become visible.
- Months 3 to 12: Body composition continues improving. Bone density gains begin showing on scans. Metabolic markers stabilize.
Monitoring and Safety Considerations
TRT isn’t without trade-offs, and ongoing blood work is a non-negotiable part of treatment. The most common issue is erythrocytosis, a condition where the body produces too many red blood cells in response to testosterone. This thickens the blood and raises the risk of clotting.
Guidelines from the American Urological Association recommend investigating if your hematocrit (the percentage of blood volume made up of red blood cells) exceeds 50%, and reducing or pausing testosterone if it reaches 54%. The Endocrine Society sets the action threshold at 54% and recommends therapeutic blood draws (phlebotomy) to bring levels back down. In practice, roughly 9 to 23% of men on testosterone-related therapies need at least one phlebotomy session during treatment.
Cardiovascular Risk
Heart safety has been the biggest question mark surrounding TRT for years. The TRAVERSE trial, the largest randomized study to date, followed over 5,100 men for an average of 22 months and found that testosterone therapy was no worse than placebo for major cardiovascular events like heart attack and stroke. That sounds reassuring, but the study had significant limitations: more than 60% of participants stopped taking their assigned treatment before the study ended, meaning many men in both groups weren’t actually on any therapy for much of the follow-up period. Earlier, smaller studies had suggested a possible increase in cardiovascular events and faster progression of arterial plaque with testosterone therapy.
The honest summary is that TRT probably doesn’t carry a large cardiovascular risk for most men, but the evidence isn’t strong enough to call it definitively safe for the heart either. This is why regular monitoring of blood pressure, cholesterol, and hematocrit remains essential throughout treatment.